1. JG Montoya, O Liesenfeld. Toxoplasmosis. The Lancet 2004; 363: 1965-1976.
2. Milne G, Webster JP, Walker M. Toxoplasma gondii: An underestimated Threat? Trends in Parasitol 2020; 36: 959-969.
3. Dubey JP. Biology of Toxoplasma gondii. In: Toxoplasmosis of Animals and Humans. 3rd edition. CRC Press, Taylor and Francis Group; 2022 https://doi.org/10.1201/9781003199373
4. Petersen E, Meroni V, Vasconcelos-Santos DV, Mandelbrot L, Peyron F. Congenital toxoplasmosis: Should we still care about screening? Food and Waterborne Parasitology 2022; 27: e00162,
5. Xia J, Venkat A, Bainbridge RE, et al. Third-generation sequencing revises the molecular karyotype for Toxoplasma gondii and identifies emerging copy number variants in sexual recom-bi-
nants. Genome Res 2021; 31: 834–851.
6. Blader IJ, Coleman BI, Chen CT, Gubbels MJ. Lytic Cycle of Toxoplasma gondii: 15 Years Later. Annu Rev Microbiol 2015; 69: 463-85.
7. CDC: DPDx – Laboratory Identification of Parasitic Diseases of Public Health Concern: Toxoplasmosis. https://www.cdc.gov/dpdx/toxoplasmosis/index.html Erişim tarihi: 9 Mart 2024
8. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 2013; 91:501–508.
9. Torgerson PR, Devleesschauwer B, Praet N, et al. World Health Organization Estimates of the Global and Regional Disease Burden of 11 Foodborne Parasitic Diseases, 2010: A Data Synthesis.
PLoS Med 2015; 12: e1001920.
10. Wang ZD, Wang SC, Liu HH, et al. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV 2017; 4: e177–e188.
11. Martin-Iguacel R, Ahlstram MG, Touma M, et al. Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era. J Infect 2017; 75: 263-
273.
12. Pinto-Ferreira F, Caldart ET, Pasquali AKS, Mitsuka-Breganó R, Freire RL, Navarro IT. Patterns of transmission and sources of infection in outbreaks of human toxoplasmosis. Emerg Infect
Dis 2019; 25:2177-2182.
13. Calero-Bernal R, Salas-Fajardo MY, Ríos A, et al. Anti-Toxoplasma gondii Antibodies in European Residents: A Systematic Review and Meta-Analysis of Studies Published between 2000 and
2020. Pathogens. 2023; 12: 1430-1456.
14. Johnson HJ, Koshy AA. Latent toxoplasmosis effects on rodents and humans: how much is real and how much is media hype? mBio 2020; 11: e02164-19.
15. Karakavuk M, Can H, Selim N, et al. Investigation of the role of stray cats for transmission of toxoplasmosis to humans and animals living in İzmir, Turkey. J Infect Dev Ctries 2021; 15:
155–162.
16. Karatepe B, Babür C, Karatepe M, Kılıç S, Dündar B. Prevalence of Toxoplasma gondii and intestinal parasites in stray cats from Nigde, Turkey. Ital J Anim Sci 2008; 7: 113-118.
17. Baştan I, Bas B. Clinical and some laboratory findings in cats with toxoplasmosis. Turkish J Vet Res 2018; 2: 1–4.
18. Alver O, Payaslıoğlu M, Ener B. Uludağ Üniversitesi Tıp Fakültesi Hastanesi’nde 2009-2016 yılları arasında Toxoplasma gondii seropozitifliğinin dağılımı. Turkiye Parazitol Derg 2019; 43:
Suppl 1: 8-12.
19. Aycan ÖM, Miman Ö, Atambay M, Karaman Ü, Çelik T, Daldal N. Hastanemizde son yedi yıllık Toxoplasma gondii seropozitifliğinin araştırılması. İnönü Üniversitesi Tıp Fakültesi Dergisi
2008; 15: 199-201.
20. Çiçek AÇ, Duygu F, İnakçı İH, Nuray Boyar N, Boyar İH. Şanlıurfa ilinde doğurganlık çağındaki kadınlarda ELISA ile Toxoplasma gondii antikorlarının araştırılması: Üç yıllık değerlendirme.
J Clin Exp Invest 2012; 3: 61-5.
21. Dubey JP. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol 2008; 38:1257-78.
22. Portes J, Barrias E, Travassos R, Attias M, de Souza W. Toxoplasma gondii Mechanisms of Entry Into Host Cells. Front Cell Infect Microbiol 2020; 10: 294.
23. Toxoplasmosis. Clinical Overview. Erişim adresi: https://www.clinicalkey.com/#!/content/67-s2.0-1e23d0e6-7351-41e3-88d0-5cdfeba11cf4.
24. Demar M, Hommel D, Djossou F, et al. Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin Microbiol Infect 2012; 18:E221
25. Dubey JP. Toxoplasma gondii Infections in Humans (Homo sapiens). In: Toxoplasmosis of Animals and Humans. 3rd edition. CRC Press, Taylor and Francis Group; 2022. https://doi.
org/10.1201/9781003199373
26. Sabın AB. Toxoplasmic encephalitis in children. JAMA. 1941; 116: 801–807.
27. Gomez-Marin JE, de la Torre A. Ocular disease due to Toxoplasma gondii. In Weiss LM, Kim K. (Eds), Toxoplasma gondii: The Model Apicomplexan – Perspectives and Methods. 3rd ed.
Academic Press. London, 2020; 229–291.
28. Rothova A, Suttorp-van Schulten MSA, Treffers WF, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996; 80: 332–336.
29. Sobanski V, Ajzenberg D, Delhaes L, Bautin N, Just N. Severe toxoplasmosis in immunocompetent hosts: Be aware of atypical strains. Am J Respir Crit Care 2013; 187: 1143–1145.
30. Rogers NM, Peh CA, Faull R, Pannell M, Cooper J, Russ GR. Transmission of toxoplasmosis in two renal allograft recipients receiving an organ from the same donor. Transplant Infect Dis
2008; 10: 71–74.
31. Tyebji S, Seizova S, Hannan AJ, Tonkin CJ. Toxoplasmosis: A pathway to neuropsychiatric disorders. Neurosci Biobehav Rev 2019; 96: 72–92.
32. Conejero-Goldberg C, Torrey EF, Yolken RH. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophrenia Res 2003; 60: 65–69.
33. Samojlowicz D, Twarowska-Malczyńska J, Borowska-Solonynko A, Poniatowski LA, Sharma N, Olczak M. Presence of Toxoplasma gondii infection in brain as a potential cause of risky
behavior: A report of 102 autopsy cases. Eur J Clin Microbiol Infect Dis 2019; 38: 305–317.
34. Desmonts G, Couvreur J. Congenital toxoplasmosis: A prospective study of 378 pregnancies. N Engl J Med 1974; 290: 1110–1116.
35. Gras L, Wallon M, Pollak A. European Multicenter Study on Congenital Toxoplasmosis: Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in
infancy: A cohort study in 13 European centres. Acta Paediatrica 2005; 94: 1721–1731.
36. Ferri FF. Toxoplasmosis. Ferri’s Clinical Advisor 2024 Elsevier 1376-1378.e1.
37. Dubey JP. Techniques for Studying Toxoplasma gondii. In: Toxoplasmosis of Animals and Humans. 3rd edition. CRC Press, Taylor and Francis Group; 2022. https://doi.org/10.1201/9781003199373
38. El Mansouri B, Amarir, Peyron F, et al. High performance of a novel point-of-care blood test for Toxoplasma infection in women from diverse regions of Morocco. Emerging Microbes &
Infections 2021; 10:1675-1682.
39. Daher D, Shaghlil A, Sobh, E, et al. Comprehensive overview of Toxoplasma gondii-induced and associated diseases. Pathogens 2021; 10: 1351-1369.
40. Montoya JG, Boothroyd JC, Kovacs JA. Toxoplasma gondii. In: Benneth JE, Dolin R, Blaser MJ (eds). Principles and Practice of Infectious Diseases 2015; 3122; Philadelphia: Elsevier Saunders
41. Schwartzman JD, Petersen E. Diagnostic testing for toxoplasmosis infection. In: UpToDate, Weller P, eds. Wolters Kluwer. (Erişim Tarihi: 8 Mart 2024).
42. Mandelbrot L. Congenital toxoplasmosis: What is the evidence for chemoprophylaxis to prevent fetal infection? Prenat Diagn 2020; 40: 1693-1702.
43. Dunay IR, Gajurel K, Dhakal R, et al. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev 2018; 31.
44. Sinai AP, Watts EA, Dhara A, Murphy RD, Gentry MS, Patwardhan A. Reexamining chronic Toxoplasma gondii infection: surprising activity for a ‘Dormant’ parasite. Curr Clin Microbiol
Reports 2016; 3:175–85.
45. Loh FK, Nathan S, ChowSC, Fang CM. Vaccination challenges and strategies against long-lived Toxoplasma gondii. Vaccine 2019; 37: 3989-4000.
46. Ağalar C, Akarsu GA, Aksay AK, ve ark. Toksoplazmoz Tanı ve Tedavi Uzlaşı Raporu. Bilimsel Tıp Yayınevi. 2022. Ağalar C, Çağ Y, Kurtaran B, Pullukçu H, Taşbakan MI eds.
47. Montazeri M, Sharif M , Sarvi S, Mehrzadi S, Ahmadpour E, Daryani A. A systematic review of in vitro and in vivo activities of anti-Toxoplasma drugs and compounds (2006-2016). Front
Microbiol 2017; 8: 25.
48. Aguirre AA, Longcore T, Barbieri M, et al. The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies. Ecohealth 2019; 16: 378-390.
49. Belluco S, Simonato G, Mancin M, Pietrobelli M, Ricci A. Toxoplasma gondii infection and food consumption: A systematic review and meta-analysis of case-controlled studies. Crit Rev Food
Sci Nutr 2018; 58: 3085–3096